Fundraising FoxCoral Capital — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
Provigate develops a low/non-invasive, low-cost home glucose monitoring service based on weekly glycated albumin (GA) testing from finger-prick blood or saliva samples via mail-in and point-of-care testing, paired with a coaching app and a remote monitoring dashboard for clinicians.
BiotechDigital HealthMedical DevicesTokyo, JP
Koshin Sekimizu, PhD(Founder)in
PartnerJames Riney· solo GP
Co-investorsANRISPARX Group
Polyuse is a Japanese company developing construction 3D printers and related technology and services for the construction industry.
Advanced ManufacturingConstruction TechHardwareTokyo, JP
hayato isezaki(Founder)in岩本 卓也(代表取締役/共同創業者)大岡 航(代表取締役/共同創業者)
PartnerJames Riney· solo GP
Co-investorsGlobis Capital PartnersSTRIVEUniversal Materials IncubatorWorld Innovation Lab (WiL)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.